Medication Guide - 8/30/2021

Medication guides are FDA- approved documents that address issues that are specific to particular drugs, and can help patients avoid serious adverse events (side effects). This database does not include Medication Guides for FDA-approved allergenic or cellular/tissue products (see  FDA Online Label Repository  or DailyMed  for these Medication Guides).  More Drug Name Active Ingredient Form;Route Appl. No. Company Date Nexium Esomeprazole Magnesium CAPSULE, DELAYED REL PELLETS;ORAL 021153 ASTRAZENECA 08/25/2021 Nexium Esomeprazole Magnesium FOR SUSPENSION, DELAYED RELEASE;ORAL 021957 ASTRAZENECA 08/25/2021 Nexium Esomeprazole Magnesium FOR SUSPENSION, DELAYED RELEASE;ORAL 022101 ASTRAZENECA 08/25/2021 Tibsovo Ivosidenib TABLET;ORAL 211192 SERVIER 08/25/2021 Linzess Linaclotide CAPSULE;ORAL 202811 ALLERGAN 08/24/2021 Mayzent Siponimod Fumaric Acid TABLET;ORAL 209884 NOVARTIS 08/24/2021 Xarelto Rivaroxaban TABLET;ORAL 022406 JANSSEN PHARMS 08/23/2021 Xarelto Rivaroxaban TABLET;ORAL 202439 JANSSEN PHARMS 08/23/2021 Manage Subscriptions  |  Unsubscribe All  |  Help This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA